Shuichi Okada

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Topics

Peritoneal Dialysis

Top Venues

JCEM case reports

Journal of diabetes

Journal of health, population, and nutrition

This page only lists publications with an associated author ORCID identifier.

Publications

Shuichi Okada, Kazuya Okada, Junichi Okada, Eijiro Yamada
Imeglimin Improved Plasma Glucose Levels in Patients With Latent Autoimmune Diabetes of Adults: Report of 2 Cases. JCEM case reports 2 (1) (2023)
Shuichi Okada, Kazuya Okada, Junichi Okada, Eijiro Yamada
Imeglimin Improved Plasma Glucose Levels in Patients With Latent Autoimmune Diabetes of Adults: Report of 2 Cases. JCEM case reports 2 (1) (2023)
Ryota Uehara, Eijiro Yamada, Shuichi Okada, Claire C Bastie, Akito Maeshima, Hidekazu Ikeuchi, Kazuhiko Horiguchi, Masanobu Yamada
Fyn Phosphorylates Transglutaminase 2 (Tgm2) and Modulates Autophagy and p53 Expression in the Development of Diabetic Kidney Disease. Cells 12 (8) (2023)
Ryota Uehara, Eijiro Yamada, Shuichi Okada, Claire C Bastie, Akito Maeshima, Hidekazu Ikeuchi, Kazuhiko Horiguchi, Masanobu Yamada
Fyn Phosphorylates Transglutaminase 2 (Tgm2) and Modulates Autophagy and p53 Expression in the Development of Diabetic Kidney Disease. Cells 12 (8) (2023)
Ryota Uehara, Eijiro Yamada, Shuichi Okada, Claire C Bastie, Akito Maeshima, Hidekazu Ikeuchi, Kazuhiko Horiguchi, Masanobu Yamada
Fyn Phosphorylates Transglutaminase 2 (Tgm2) and Modulates Autophagy and p53 Expression in the Development of Diabetic Kidney Disease. Cells 12 (8) (2023)
Ryota Uehara, Eijiro Yamada, Yasuyo Nakajima, Aya Osaki, Shuichi Okada, Masanobu Yamada
Casual C peptide index: Predicting the subsequent need for insulin therapy in outpatients with type 2 diabetes under primary care. Journal of diabetes 14 (3) (2022)
Junichi Okada, Noriaki Sunaga, Eijiro Yamada, Tsugumichi Saito, Atsushi Ozawa, Yasuyo Nakajima, Kazuya Okada, Jeffrey E Pessin, Shuichi Okada, Masanobu Yamada
FAM83G Is a Novel Inducer of Apoptosis. Molecules (Basel, Switzerland) 25 (12) (2020)
Takuya Watanabe, Atsushi Ozawa, Shinnosuke Masuda, Satoshi Yoshino, Emi Ishida, Yuri Kondo, Shunichi Matsumoto, Akiko Katano-Toki, Kazuhiko Horiguchi, Yasuyo Nakajima, Eijiro Yamada, Takuya Tomaru, Tsugumichi Saito, Sumiyasu Ishii, Nobuyuki Shibusawa, Shuichi Okada, Tetsurou Satoh, Masanobu Yamada
Transcriptional Regulation of the Angptl8 Gene by Hepatocyte Nuclear Factor-1 in the Murine Liver. Scientific reports 10 (1) (2020)
Junichi Okada, Eijiro Yamada, Yawara Niijima, Shuichi Okada, Masanobu Yamada
Comparison of serum amylase level between dipeptidyl peptidase-4 inhibitor and GLP-1 analog administration in patients with type 2 diabetes mellitus. Journal of health, population, and nutrition 38 (1) (2019)
Junichi Okada, Eijiro Yamada, Yawara Niijima, Shuichi Okada, Masanobu Yamada
Dipeptidyl peptidase-4 inhibitors attenuate thyroid-stimulating hormone concentrations. Journal of diabetes 11 (6) (2019)
Aya Osaki, Yoko Shimoda, Junichi Okada, Eijiro Yamada, Tsugumichi Saito, Yasuyo Nakajima, Atsushi Ozawa, Yawara Niijima, Shuichi Okada, Masanobu Yamada
Lower Renal Threshold for Glucose Reabsorption in Type 1 Diabetes Mellitus (T1DM) May Explain the Smaller Contribution of SGLT2 Inhibitors to the Improvement of Plasma Glucose Control Compared with T2DM. Diabetes therapy : research, treatment and education of diabetes and related disorders 10 (4) (2019)